Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA41851
Max Phase: Preclinical
Molecular Formula: C38H43F2N3O9
Molecular Weight: 723.77
Molecule Type: Small molecule
Associated Items:
ID: ALA41851
Max Phase: Preclinical
Molecular Formula: C38H43F2N3O9
Molecular Weight: 723.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)C[C@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)C(O)c1ccccc1-c1ccccc1)C(=O)N[C@H]1C[C@@H](C(=O)O)C[C@@H](C(=O)O)C1
Standard InChI: InChI=1S/C38H43F2N3O9/c1-20(2)33(35(47)41-27-16-23(37(49)50)15-24(17-27)38(51)52)43-32(45)19-31(44)30(14-21-12-25(39)18-26(40)13-21)42-36(48)34(46)29-11-7-6-10-28(29)22-8-4-3-5-9-22/h3-13,18,20,23-24,27,30-31,33-34,44,46H,14-17,19H2,1-2H3,(H,41,47)(H,42,48)(H,43,45)(H,49,50)(H,51,52)/t23-,24+,27-,30-,31-,33-,34?/m0/s1
Standard InChI Key: DIPNZVXJUGCGCY-KAUMSOOVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 723.77 | Molecular Weight (Monoisotopic): 723.2967 | AlogP: 3.35 | #Rotatable Bonds: 15 |
Polar Surface Area: 202.36 | Molecular Species: ACID | HBA: 7 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.82 | CX Basic pKa: | CX LogP: 3.42 | CX LogD: -2.69 |
Aromatic Rings: 3 | Heavy Atoms: 52 | QED Weighted: 0.12 | Np Likeness Score: -0.08 |
1. Hom RK, Gailunas AF, Mamo S, Fang LY, Tung JS, Walker DE, Davis D, Thorsett ED, Jewett NE, Moon JB, John V.. (2004) Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase., 47 (1): [PMID:14695829] [10.1021/jm0304008] |
Source(1):